Medicus Pharma Ltd.
MDCX
$1.73
-$0.19-9.66%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 13.78M | 10.53M | 8.23M | 6.50M | 8.97M |
| Depreciation & Amortization | -78.40K | -78.40K | -78.40K | -78.40K | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.20M | 15.83M | 13.37M | 9.95M | 11.17M |
| Operating Income | -20.20M | -15.83M | -13.37M | -9.95M | -11.17M |
| Income Before Tax | -34.49M | -15.83M | -13.29M | -9.89M | -9.00M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -34.49 | -15.83 | -13.29 | -9.89 | -9.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 100.00 | -- | -- | -- | -- |
| Net Income | -34.49M | -15.83M | -13.29M | -9.89M | -9.00M |
| EBIT | -20.20M | -15.83M | -13.37M | -9.95M | -11.17M |
| EBITDA | -2.32M | -4.63M | -8.16M | -9.92M | -7.59M |
| EPS Basic | -2.17 | -1.29 | -1.30 | -1.10 | -1.07 |
| Normalized Basic EPS | -1.04 | -0.80 | -0.81 | -0.68 | -0.65 |
| EPS Diluted | -2.17 | -1.29 | -1.30 | -1.10 | -1.07 |
| Normalized Diluted EPS | -1.04 | -0.80 | -0.81 | -0.68 | -0.65 |
| Average Basic Shares Outstanding | 56.52M | 47.40M | 41.29M | 37.12M | 33.89M |
| Average Diluted Shares Outstanding | 56.52M | 47.40M | 41.29M | 37.12M | 33.89M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |